21st Century Oncology Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:21st Century Oncology Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3309
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
21st Century Oncology Inc. (21st Century Oncology), a subsidiary of 21st Century Oncology Holdings, Inc., is a provider of integrated cancer care services (ICC). It operates through an integrated network of cancer treatment centers and affiliated physicians with specialization in radiation oncology, breast, gynecological and general surgery, medical oncology, urology and primary care. Its physicians provide their services in partnership with health systems. Its service portfolio includes external beam therapy services and internal radiation therapy services. It carries out most of its operations under the 21st Century Oncology brand. The company operates through international treatment centers operations in the US and in certain Latin American markets. 21st Century Oncology is headquartered in Fort Myers, Florida, the US.

21st Century Oncology Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
21st Century Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
21st Century Oncology Inc, Medical Devices Deals, 2012 to YTD 2018 9
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deal Details 11
Debt Offering 11
Radiation Therapy Services Completes Private Placement Of Notes Due 2017 For US$350 Million 11
Acquisition 13
21st Century Oncology Acquires Remaining 35% Stake in South Florida Radiation Oncology 13
21st Century Oncology Acquires 65% Stake In South Florida Radiation Oncology For US$60 Million 14
Radiation Therapy Services Completes Acquisition Of OnCure For US$125 Million 16
21st Century Oncology Inc – Key Competitors 18
21st Century Oncology Inc – Key Employees 19
21st Century Oncology Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 23
Corporate Communications 23
Apr 18, 2018: 21st Century Oncology Names Kimberly Commins-Tzoumakas As Chief Executive Officer 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Key Facts 2
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
21st Century Oncology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
21st Century Oncology Inc, Deals By Therapy Area, 2012 to YTD 2018 8
21st Century Oncology Inc, Medical Devices Deals, 2012 to YTD 2018 9
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Radiation Therapy Services Completes Private Placement Of Notes Due 2017 For US$350 Million 11
21st Century Oncology Acquires Remaining 35% Stake in South Florida Radiation Oncology 13
21st Century Oncology Acquires 65% Stake In South Florida Radiation Oncology For US$60 Million 14
Radiation Therapy Services Completes Acquisition Of OnCure For US$125 Million 16
21st Century Oncology Inc, Key Competitors 18
21st Century Oncology Inc, Key Employees 19
21st Century Oncology Inc, Other Locations 20
21st Century Oncology Inc, Subsidiaries 21

List of Figures
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
21st Century Oncology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
21st Century Oncology Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[21st Century Oncology Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Consort Medical plc (CSRT):医療機器:M&Aディール及び事業提携情報
    Summary Consort Medical plc (Consort Medical) is a contract development and manufacturing organization (CDMO) with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and point-of-care (POC) diagnostic …
  • AstraZeneca AB-製薬・医療分野:企業M&A・提携分析
    Summary AstraZeneca AB (AstraZeneca), a subsidiary of AstraZeneca Plc is a healthcare products provider that research and development of medicinal products. The company offers research and produces drug products in heart and cardiovascular, infection, cancer, metabolic diseases, respiratory, stomach …
  • Malakoff Corporation Berhad:発電所・企業SWOT分析
    Malakoff Corporation Berhad - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key e …
  • Fiat Chrysler Automobiles NV:企業の戦略・SWOT・財務情報
    Fiat Chrysler Automobiles NV - Strategy, SWOT and Corporate Finance Report Summary Fiat Chrysler Automobiles NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Coffee Republic Trading Ltd:企業の戦略・SWOT・財務分析
    Coffee Republic Trading Ltd - Strategy, SWOT and Corporate Finance Report Summary Coffee Republic Trading Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Oriola-KD Oyj (OKDBV):企業の財務・戦略的SWOT分析
    Oriola-KD Oyj (OKDBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mentor Graphics Corporation:企業の戦略・SWOT・財務分析
    Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report Summary Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • ExxonMobil Pipeline Co:石油・ガス:M&Aディール及び事業提携情報
    Summary ExxonMobil Pipeline Co (EMPCO) a subsidiary of Exxon Mobil Corporation is an oil and gas company that offers petroleum products transportation solutions. The company transports crude oil, refined products, liquefied petroleum gases, natural gas liquids and chemical feed-stocks. Its distribut …
  • Zimmer Biomet Holdings Inc (ZBH):企業の財務・戦略的SWOT分析
    Zimmer Biomet Holdings Inc (ZBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Hotel Dubrovnik d.d.:企業の戦略・SWOT・財務分析
    Hotel Dubrovnik d.d. - Strategy, SWOT and Corporate Finance Report Summary Hotel Dubrovnik d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Eurocommercial Properties NV:企業の戦略・SWOT・財務分析
    Eurocommercial Properties NV - Strategy, SWOT and Corporate Finance Report Summary Eurocommercial Properties NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Newfield Exploration Co (NFX):石油・ガス:M&Aディール及び事業提携情報
    Summary Newfield Exploration Co (Newfield) is an independent upstream company. The company focuses on onshore large scale, liquids-rich resource plays. Its domestic assets are in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota and the Uinta Basin of Utah. The company …
  • Hitachi Zosen Corporation:企業の戦略・SWOT・財務分析
    Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report Summary Hitachi Zosen Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • BNP Paribas Cardif:企業の戦略・SWOT・財務情報
    BNP Paribas Cardif - Strategy, SWOT and Corporate Finance Report Summary BNP Paribas Cardif - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Recylex SA:企業の戦略・SWOT・財務情報
    Recylex SA - Strategy, SWOT and Corporate Finance Report Summary Recylex SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Barclaycard:企業の戦略・SWOT・財務分析
    Barclaycard - Strategy, SWOT and Corporate Finance Report Summary Barclaycard - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Biocodex-製薬・医療分野:企業M&A・提携分析
    Summary Biocodex (Biocodex) is a drug manufacturing company that develops and commercializes drugs. The company offers products for gastro enteric diseases, pain management, neurological and psychiatric conditions, rheumatic pains, and ENT conditions. Its products include Saccharomyces boulardii, an …
  • Vossloh AG:企業のM&A・事業提携・投資動向
    Vossloh AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Vossloh AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Lear Corporation:企業の戦略・SWOT・財務情報
    Lear Corporation - Strategy, SWOT and Corporate Finance Report Summary Lear Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Akers Biosciences Inc (AKER):企業の財務・戦略的SWOT分析
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. ABI products include BreathScan alcohol detectors, CHUBE, METRO …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆